DrugCite
Search

MEDROXYPROGESTERONE AND MEDROXYPROGESTERONE ACETATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Medroxyprogesterone And Medroxyprogesterone Acetate Adverse Events Reported to the FDA Over Time

How are Medroxyprogesterone And Medroxyprogesterone Acetate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Medroxyprogesterone And Medroxyprogesterone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Medroxyprogesterone And Medroxyprogesterone Acetate is flagged as the suspect drug causing the adverse event.

Most Common Medroxyprogesterone And Medroxyprogesterone Acetate Adverse Events Reported to the FDA

What are the most common Medroxyprogesterone And Medroxyprogesterone Acetate adverse events reported to the FDA?

Breast Cancer
4701 (12.48%)
Breast Cancer Female
4185 (11.11%)
Unintended Pregnancy
774 (2.05%)
Amenorrhoea
585 (1.55%)
Drug Ineffective
550 (1.46%)
Weight Increased
524 (1.39%)
Metrorrhagia
440 (1.17%)
Headache
427 (1.13%)
Menorrhagia
416 (1.1%)
Breast Cancer Metastatic
415 (1.1%)
Osteoporosis
414 (1.1%)
Show More Show More
Depression
363 (.96%)
Nausea
306 (.81%)
Dizziness
301 (.8%)
Drug Exposure During Pregnancy
296 (.79%)
Pain
273 (.72%)
Anxiety
264 (.7%)
Abortion Spontaneous
231 (.61%)
Injection Site Reaction
230 (.61%)
Ovarian Cancer
230 (.61%)
Breast Cancer In Situ
225 (.6%)
Fatigue
207 (.55%)
Pregnancy With Injectable Contracep...
204 (.54%)
Breast Operation
203 (.54%)
Inappropriate Schedule Of Drug Admi...
201 (.53%)
Oestrogen Receptor Assay Positive
194 (.51%)
Arthralgia
192 (.51%)
Osteopenia
187 (.5%)
Alopecia
181 (.48%)
Vaginal Haemorrhage
177 (.47%)
Thrombosis
173 (.46%)
Pulmonary Embolism
168 (.45%)
Dyspnoea
167 (.44%)
Insomnia
165 (.44%)
Cerebrovascular Accident
158 (.42%)
Pain In Extremity
157 (.42%)
Back Pain
154 (.41%)
Weight Decreased
151 (.4%)
Vomiting
150 (.4%)
Abdominal Pain
149 (.4%)
Malaise
149 (.4%)
Asthenia
147 (.39%)
Progesterone Receptor Assay Positiv...
147 (.39%)
Bone Density Decreased
145 (.38%)
Injection Site Pain
145 (.38%)
Hot Flush
144 (.38%)
Mastectomy
141 (.37%)
Migraine
139 (.37%)
Feeling Abnormal
134 (.36%)
Hypertension
133 (.35%)
Condition Aggravated
130 (.35%)
Haemorrhage
128 (.34%)
Rash
122 (.32%)
Mood Swings
121 (.32%)
Urticaria
121 (.32%)
Myocardial Infarction
120 (.32%)
Incorrect Dose Administered
119 (.32%)
Abdominal Distension
116 (.31%)
Menstruation Irregular
116 (.31%)
Chest Pain
115 (.31%)
Nervousness
115 (.31%)
Hypersensitivity
113 (.3%)
Oedema Peripheral
112 (.3%)
Pruritus
109 (.29%)
Deep Vein Thrombosis
102 (.27%)
Hypoaesthesia
101 (.27%)
Pelvic Pain
100 (.27%)
Tremor
98 (.26%)
Anaemia
97 (.26%)
Dysmenorrhoea
96 (.25%)
Muscle Spasms
96 (.25%)
Acne
92 (.24%)
Syncope
89 (.24%)
Irritability
87 (.23%)
Drug Ineffective For Unapproved Ind...
83 (.22%)
Injection Site Abscess
81 (.22%)
Paraesthesia
80 (.21%)
Injury
77 (.2%)
Abdominal Pain Upper
74 (.2%)
Infertility Female
74 (.2%)
Breast Pain
72 (.19%)
Mood Altered
70 (.19%)
Ovarian Cyst
70 (.19%)
Somnolence
70 (.19%)
Lymphoedema
69 (.18%)
Blood Pressure Increased
68 (.18%)
Swelling
68 (.18%)
Vision Blurred
67 (.18%)
Convulsion
66 (.18%)
Suicidal Ideation
65 (.17%)
Uterine Haemorrhage
65 (.17%)
Uterine Leiomyoma
62 (.16%)
Crying
61 (.16%)
Pyrexia
61 (.16%)
Drug Interaction
60 (.16%)
Emotional Disorder
60 (.16%)
Diarrhoea
59 (.16%)
Fall
58 (.15%)
Hyperhidrosis
58 (.15%)
Loss Of Consciousness
58 (.15%)
Pregnancy
58 (.15%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Medroxyprogesterone And Medroxyprogesterone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Medroxyprogesterone And Medroxyprogesterone Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Medroxyprogesterone And Medroxyprogesterone Acetate

What are the most common Medroxyprogesterone And Medroxyprogesterone Acetate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Medroxyprogesterone And Medroxyprogesterone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Medroxyprogesterone And Medroxyprogesterone Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Medroxyprogesterone And Medroxyprogesterone Acetate According to Those Reporting Adverse Events

Why are people taking Medroxyprogesterone And Medroxyprogesterone Acetate, according to those reporting adverse events to the FDA?

Hormone Replacement Therapy
25559
Contraception
3798
Menopausal Symptoms
1802
Menopause
1071
Drug Use For Unknown Indication
271
Off Label Use
262
Show More Show More
Ill-defined Disorder
210
Menstrual Discomfort
175
Endometriosis
162
Menorrhagia
161
Hot Flush
152
Product Used For Unknown Indication
143
Amenorrhoea
100
Hormone Therapy
97
Menstruation Irregular
76
Osteoporosis
59
Breast Cancer
56
Uterine Leiomyoma
56
Dysmenorrhoea
55
Prophylaxis
53
Uterine Haemorrhage
43
Vaginal Haemorrhage
37
Osteoporosis Prophylaxis
37
Menstrual Disorder
36
Premenstrual Syndrome
31
Cardiac Disorder
23
Ovarian Cyst
22
Oestrogen Replacement Therapy
20
Menstrual Cycle Management
20
Hysterectomy
20
Breast Cancer Metastatic
19
Endometrial Hyperplasia
18
Uterine Cancer
17
Migraine
16
Polycystic Ovaries
16
Metrorrhagia
16
Decreased Appetite
15
Mood Swings
14
Breast Cancer Recurrent
14
Anorexia
12
Genital Disorder Female
12
Lymphangioleiomyomatosis
11
Pelvic Pain
11
Endometrial Cancer
11
Night Sweats
11
Dysfunctional Uterine Bleeding
10
Anovulatory Cycle
9
Hormone Level Abnormal
9
Menometrorrhagia
9
Injectable Contraception
9
Haemorrhage
8

Drug Labels

LabelLabelerEffective
ProveraPharmacia and Upjohn Company13-AUG-09
Medroxyprogesterone AcetatePhysicians Total Care, Inc.13-AUG-09
Medroxyprogesterone AcetatePhysicians Total Care, Inc.13-AUG-09
Medroxyprogesterone AcetateRebel Distributors Corp.04-OCT-10
Depo-proveraPhysicians Total Care, Inc.27-OCT-10
Depo-subq ProveraPharmacia and Upjohn Company30-NOV-10
Medroxyprogesterone AcetatePD-Rx Pharmaceuticals, Inc.18-JAN-11
Medroxyprogesterone AcetateBlenheim Pharmacal, Inc.02-JUN-11
Medroxyprogesterone AcetateREMEDYREPACK INC. 07-JUN-11
Medroxyprogesterone AcetateCardinal Health10-JUN-11
Medroxyprogesterone AcetateGreenstone LLC01-SEP-11
Medroxyprogesterone AcetatePreferred Pharmaceuticals, Inc08-SEP-11
Medroxyprogesterone AcetateAmerican Health Packaging27-JAN-12
Medroxyprogesterone AcetatePreferred Pharmaceuticals, Inc13-FEB-12
Depo-proveraPharmacia and Upjohn Company26-JUN-12
Medroxyprogesterone AcetateTeva Parenteral Medicines, Inc13-AUG-12
Medroxyprogesterone AcetateBarr Laboratories Inc.06-SEP-12
Medroxyprogesterone AcetateDispensing Solutions, Inc.28-SEP-12
PremphaseWyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.30-SEP-12
PremproWyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.30-SEP-12
Medroxyprogesterone AcetateGreenstone LLC09-OCT-12
PremproPhysicians Total Care, Inc.01-NOV-12
PremphasePhysicians Total Care, Inc.26-NOV-12
Medroxyprogesterone AcetateBryant Ranch Prepack17-JAN-13
Medroxyprogesterone AcetateBryant Ranch Prepack17-JAN-13
Medroxyprogesterone AcetateBryant Ranch Prepack21-JAN-13
PremproDispensing Solutions, Inc.27-FEB-13
Medroxyprogesterone Acetate PD-Rx Pharmaceuticals, Inc.28-FEB-13

Medroxyprogesterone And Medroxyprogesterone Acetate Case Reports

What Medroxyprogesterone And Medroxyprogesterone Acetate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Medroxyprogesterone And Medroxyprogesterone Acetate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Medroxyprogesterone And Medroxyprogesterone Acetate.